ABBV or DIVISLAB.NS: which has stronger momentum now?
As of 2026-09-01: ABBV LONG (67 bars, uPnL +20.3%, total return +25.0%) vs DIVISLAB.NS LONG (218 bars, uPnL +40.9%, total return +25.3%). Momentum is the fourth gate — quality and valuation ceilings come first.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| ABBV (AbbVie) | DIVISLAB.NS (Divi's Laboratories) | |
| Market / sector | us · Healthcare | in · Pharma |
| Price | $258.15 | ₹9,121 |
| Quality score | 100/100 | —/100 |
| Engine signal | LONG · 67 bars · uPnL +20.3% | LONG · 218 bars · uPnL +40.9% |
| Total return | +25.0% | +25.3% |
Cite this page
Balance Labs Research Desk (2026-09-01). "ABBV or DIVISLAB.NS: which has stronger momentum now?." balancelabs.app · https://balancelabs.app/stocks/compare/abbv-vs-divislab.ns/q/abbv-or-divislab.ns-stronger-momentum · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← ABBV vs DIVISLAB.NS · snapshot 2026-09-01 · not investment advice